Results 251 to 260 of about 646,696 (338)

External quality assessment to support the WHO ProSPeRo study for the evaluation of two dual HIV/syphilis point-of-care tests in seven countries. [PDF]

open access: yesBMC Infect Dis
Cao W   +16 more
europepmc   +1 more source

Annual Report on External Quality Assessment of Blood Bank Tests in Korea (2013)

open access: gold, 2014
Young Ae Lim   +11 more
openalex   +2 more sources

External Quality Assessment for Zika Virus Molecular Diagnostic Testing, Brazil

open access: yesEmerging Infectious Diseases, 2018
Sally A. Baylis, Johannes Blümel
doaj   +1 more source

Design of external quality assessment (EQA) schemes and definition of the roles of their providers in future epidemics

open access: yes, 2022
Buchta C   +14 more
europepmc   +1 more source

AB022. External quality assessment of clinical genetics: from pilot assessment to full external quality assurance scheme

open access: yesAnnals of Translational Medicine, 2017
Borut Peterlin   +4 more
openaire   +3 more sources

Relationship of cognitive decline with glucocerebrosidase activity and amyloid‐beta 42 in DLB and PD

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
Abstract Objective Dementia with Lewy bodies (DLB) and Parkinson's disease (PD) share clinical, pathological, and genetic risk factors, including GBA1 and APOEε4 mutations. Biomarkers associated with the pathways of these mutations, such as glucocerebrosidase enzyme (GCase) activity and amyloid‐beta 42 (Aβ42) levels, may hold potential as predictive ...
Maria Camila Gonzalez   +15 more
wiley   +1 more source

Annual Report on External Quality Assessment Scheme in Clinical Microbiology in Korea (2013)

open access: gold, 2014
Young Jin Ko   +15 more
openalex   +2 more sources

Evidence of blood–brain barrier dysfunction and CSF immunoglobulin synthesis in Down Syndrome Regression Disorder

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
Abstract Objectives This study sought to evaluate proteomic, metabolomic, and immune signatures in the cerebrospinal fluid of individuals with Down Syndrome Regression Disorder (DSRD). Methods A prospective case–control study comparing proteomic, metabolomic, and immune profiles in individuals with DSRD was performed.
Jonathan D. Santoro   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy